Medicamen Organics Reports H1 FY27 Results and Preferential Fundraise Utilisation
Medicamen Organics Ltd · Outcome · 16 Nov 2026, 8:33 pm
Medicamen Organics Reports H1 FY27 Results and Preferential Fundraise Utilisation Medicamen Organics reported consolidated revenue from operations of ₹699.05 Lakhs for the half-year ended 30th Sep'26, down YoY from ₹1,785.23 Lakhs, with a net loss of ₹414.78 Lakhs versus a profit of ₹203.80 Lakhs in H1 FY26. Standalone revenue fell to ₹567.26 Lakhs, posting a net loss of ₹405.46 Lakhs. The company completed a ₹9.50 Cr preferential allotment and raised ₹12.29 Cr across equity and warrants, utilizing ₹10.92 Cr primarily for working capital without deviations. Auditor notes highlighted GST demands totaling ₹202.47 Lakhs and unreviewed Rwandan subsidiary financials.
Original exchange filing (PDF)
More announcements from Medicamen Organics Ltd
- Medicamen Organics Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 · 15 Nov 2026
- Medicamen Organics Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 15 Nov 2026
- Medicamen Organics Limited has informed the Exchange about Submission of Certificate from Statutory Auditors in terms of Regulation 169(5) of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 · 08 Nov 2026
- Medicamen Organics Limited has informed the Exchange about Allotment of 10,00,000 (Ten Lakhs) fully paid-up Equity Shares pursuant to conversion of 10,00,000 (Ten Lakhs) fully convertible warrants, on a preferential basis · 07 Nov 2026
- Medicamen Organics Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . · 14 Nov 2026
- To consider and approve the un-audited financial results for the period ended September 30, 2026 · 14 Nov 2026
- Medicamen Organics Limited has informed the Exchange regarding Change in Auditors of the company. · 26 Sept 2026
- Medicamen Organics Limited has informed the Exchange regarding Proceedings of undefined held on September 25, 2026. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results. · 26 Sept 2026
